MINC‑anti‑CD3
Autoimmune diseases
PreclinicalActive
Key Facts
About Suntec Medical
SunTec uses EGCG‑based nanocomplexes to deliver multi‑target immunotherapies for hard‑to‑treat cancers and CNS diseases.
View full company profileTherapeutic Areas
Other Autoimmune diseases Drugs
| Drug | Company | Phase |
|---|---|---|
| Humira (Adalimumab) Biosimilar | NeuClone | Early Preclinical |
| HBM7020 | Harbour BioMed | Discovery |
| R2006 | Harbour BioMed | Discovery |
| R7027 | Harbour BioMed | Discovery |
| ImmCelz™ Platform | Creative Medical Technology Holdings | Preclinical |
| Not specified in provided content | 3Sbio | Various |
| Gavocabtagene autoleucel | Astellas | Phase 1/2 |
| TYK-101 | TYK Medicines | Phase 1 |
| HCB206 | HanchorBio | Preclinical |
| miR-124 Activator | Formation Bio | Phase 2 |
| Autologous Cell Therapy Collaboration | Lupagen | Preclinical |
| Autoimmune Diagnostics Leadership Initiative | Vibrant America Clinical Laboratory | Commercial |